The potential value of tau and Aβ proteins in tears as biomarkers of AD intensity was highlighted by investigations of tear amyloid and tau levels in correlation with neurodegeneration and AD severity conducted by Gijs et al. [70]. Here, MAPT is linked to Alzheimer disease.